In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Ray Kaczmarek, Chief Executive Officer at Genezen. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Ray, covering:
- Translating military life lessons into key business leadership – taking care of your people, having operational discipline and allowing people to be leaders.
- Invaluable learnings from taking a drug from clinical trials to commercial and on-market supply.
- Insight into the booming cell and gene therapy space and how it will change the way we view medicine as a cure, not a treatment.
- The under the radar, up and coming region of Fishers, Indianapolis. Could this be the next big life science hub?
Genezen CEO Ray has over 25 years of leadership experience with the past 20 years in biotechnology and pharmaceutical operations. Ray has previously held positions including President at Nitto Avecia Pharma Services, Founder OC Biotech Consultants, SVP of GMP Operations at TriLink BioTechnologies, and VP of Manufacturing and Supply Chain Operations at Pacira Biosciences. He has supported new drug development, clinical operations, and commercial operations in biologics, vaccines, and pharmaceuticals throughout his career. Ray leads Genezen’s growth strategy and is focused on finding ways to achieve excellence for our employees, our clients, and their patients.
Please subscribe, tell your industry colleagues and join us in celebrating and promoting the value and importance of the global life science outsourcing space. We’d also appreciate a positive rating!
Molecule to Market is sponsored and funded by ramarketing. An international content, design and digital agency that helps companies in life sciences, get noticed.